N.M. KARGALTSEVA¹, O.YU. BORISOVA¹, V.I. KOCHEROVETS², A.YU. MIRONOV¹

 ¹G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow

²I.M. Sechenov First Moscow State Medical University, Moscow

 Contact details:

Kargaltseva N.M. — PhD (medicine), Researcher at the Laboratory of Diphtheria and Pertussis Infections

Address: 10 Admiral Makarov St., Moscow, Russian Federation, 125212, tel.: +7 (495)-380-20-19, e-mail: kargaltseva@mail.ru

 In many countries of the world, including Russia, the number of cases of hospital, out-of-hospital and medical care infections of bloodstream is rising and the mortality rate is high. There are repeated cases of bacteremia. There is a wide range of sources causing bloodstream infection. Risk factors include age, male gender and the presence of comorbid diseases. Secondary infection of the bloodstream of bacterial and fungal etiology complicates COVID-19. The hematological and biochemical blood parameters play the role of markers of bloodstream infection. The importance of microbiological culturomics is shown. The etiology of modern bloodstream infection is characterized by gram-positive and gram-negative bacteria, fungi and polymicrobial hemocultures.

Key words: bloodstream infection, risk factors, culturomics, markers.

REFERENCES

1. Karpin V.A., Zul’figarova B.T., Kuz’mina N.V. et al. Infective endocarditis at the turn of the century: a review. Vestnik novykh meditsinskikh tekhnologiy, 2014,  vol. 8, no. 1 (in Russ.). DOI: 10.12737/5947
2. Laupland K.B., Church K.B. Population-based epidemiology and microbiology of community – on set blood stream infections. Clin. Microbiol. Rev, 2014,  vol. 27 (4),  pp. 647–664.
3. Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis, 2010,  vol. 10 (6),  pp. 417–432.
4. Skogberg K., Lyytikainen O., Ollgren J. et al. Population-based burden of bloodstream infections in Finland. Clin. Microbiol. Infect, 2012,  vol. 18 (6),  pp. E170–E176.
5. Wilson J., Elgohari E., Livermore D.M. et al. Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clin. Microbiol. Infect, 2011,  vol. 17 (3), pp. 451–58.
6. Lychev V.G., Klester E.B. Pneumonia associated with the provision of medical care and community-acquired pneumonia: comparative characteristics, optimization of treatment. Fundamental’nye issledovaniya, 2012,  no. 7,  pp. 111–115 (in Russ.).
7. Polibin R.V., Mindlina A.Ya., Gerasimov A.A. et al. Comparative analysis of mortality from infectious diseases in the Russian Federation and some European countries. Epidemiologiya i vaktsinoprofilaktika, 2017,  vol. 94, no. 3,  pp. 4–10 (in Russ.).
8. Velasco M., Martinez A., Moreno-Martinez A. et al. Blood cultures for women with uncomplicated acute pyelonephritis: Are they necessary? Clin. Infect. Dis, 2003,  vol. 37,  pp. 1127–1130.
9. Jensen U.S., Knudsen J.D., Wehberg S. et al. Risk factors for recurrence and death after bacteremia: apopulation-based study. Clin. Microbiol. Infect, 2011,  vol. 17 (8),  pp. 1148–1154.
10. Mc Namara J.K., Righi E., Wright H. et al. Long-term morbidity and mortality following bloodstream infection: A systematic literature review. J. Infection, 2018,  vol. 77 (1),  pp. 1–8.
11. Son J.S., Song J-H., Ko K.S. et al. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. J. Korean Med. Sci, 2010,  vol. 25 (7),  pp. 992–998.
12. Chebotkevich V.N., Bessmel’tsev S.S., Kiseleva E.E. et al. Clinical and microbiological characteristics of bloodstream infection in oncohematological patients. Onkogematologiya, 2016,  vol. 11, no. 3,  pp. 58–67 (in Russ.).
13. Nedoseka V.B., Goncharov A.P. Prevention of the consequences of transient bacteremia. Klinicheskaya stomatologiya, 2002,  no. 3,  pp. 27–28 (in Russ.).
14. Goto M., Al-Hasan M.N. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin. Microbiol. Infect, 2013,  vol. 19,  pp. 501–509.
15. Lenz R., Leal J.R., Church D.L. The distinct category of healthcare associated bloodstream infections. BMC Infect. Dis, 2012,  vol. 12,  pp. 85–90.
16. Pien B.C., Sundaram P., Raoof N. et al. The clinical and prognostic importance of positive blood cultures in adults. Amer. J. of Medicine, 2010,  vol. 123 (9),  pp. 819–828.
17. Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis, 2010,  vol. 10 (6),  pp. 417–432.
18. Lillie P.J., Crump J., Hall C. et al. Long-term mortality following bloodstream infection. Clin. Microbiol. Inf, 2013,  vol. 19,  pp. 955–960.
19. Dat V.Q., Vu H.N., The H.N. et al. Bacterial bloodstream infections in a tertiary infectious diseases’ hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC Infect. Dis, 2017,  vol. 17,  pp. 493–504.
20. Al-Hasan M.N., Eckel-Passow J.E., Baddour L.M. Recurrent gram-negative bloodstream infection a 10-years population — based cohort study. J. Infect, 2010,  vol. 61,  pp. 28–33.
21. Belyalov F.I. The problem of comorbidity in diseases of internal organs. Vestnik sovremennoy klinicheskoy meditsiny, 2010,  vol. 3, no. 2,  pp. 44–47 (in Russ.).
22. Just E. Understanding risk stratification, comorbidities, and the future of healthcare. Health Catalyst, 2017,  vol. 25,  pp. 1–8.
23. Malkhazova S.M., Mironova V.A. The problem of new and re-emerging infections: tasks of medical-geographical study. Vestnik Voronezhskogo gosudarstvennogo universiteta, 2017,  no. 1,  pp. 21–31 (in Russ.).
24. Maraj B., Baddour A., Patel S. Acute colitis in a patient with Streptococcus pyogenes bacteremia. Am. J. Medicine, 2018,  vol. 131 (1),  pp. 13–14.
25. Adelman M.W., Bhamidipati D.R., Hernandez-Romieu A.C. et al. Secondary bacterial pneumonias and blood stream infections in patients hospitalized with COVID-19. Ann. Am. Thorac. Soc, 2021. DOI: 10.15.13/AnnalsATS.202009-1093RL
26. Sogaard K.K., Baetting V., Osthoff M. et al. Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J. Intensive Care, 2021,  vol. 9 (1),  pp. 1–10.
27. Bonazzetti C., Morena V., Giacomelli A. et al. Unexpectedly high frequency of Enterococcal bloodstream infections in coronavirus disease 2019 patients admitted to an Italian ICU: An observational study. Critical Care Medicine, 2021,  vol. 49 (1),  pp. e31–e40.
28. Buetti N., Ruckly S., de Montmollin E. et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric IUTCOMEREA network. Intensive Care Med, 2021,  vol. 47 ( 1),  pp. 180–187.
29. Bhatt P.J., Shiau S., Brunetti L. et al. Risk factors and outcomes of hospitalized patients with severe coronavirus disease 2019 (COVID-19) and secondary bloodstream infections: a multicenter case-control study. Clin. Infect. Dis, 2020,  XX(XX),  pp. 1–9.
30. Lagier J-C., Dubourg G., Million M. et al. Culturing the human microbiota and culturomics. Nature Reviews Microbiology, 2018,  vol. 16,  pp. 540–550.
31. Lagier J-C., Armougom F., Million M. et al. Microbial culturomics: Paradigm shift in the human gut microbiome study. Clin. Microbiol. and Infect, 2012, vol. 18 (12),  pp. 1185–1193.
32. Diekema D.J., Hsueh P.R., Mendes R.E. et al. The microbiology of bloodstream infections: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrobial Agents and Chemotherapy, 2019,  vol. 63 (7),  pp. 1–10.
33. Anderson D.J., Moehring R.W., Sloane R. et al. Bloodstream infections in community hospitals in the 21st century: A multicenter cohort study. Plos One, 2014,  vol. 9 (3),  p. e91713.
34. Lin L., ZhaoC-H., YinX-Y. et al. Aspergillus niger bloodstream infection in gastric cancer after common hepatic artery embolization: A case report. Experimental Therapeutic Medicine, 2017,  vol. 14,  pp. 1427–1432.
35. Towns M.L., Jarvis W.R., Hsueh P.R. Guidelines on blood cultures. J. Microbiol. Immunol. Infect, 2010,  vol. 43 (4),  pp. 347–349.